相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod
Alessandro d'Ambrosio et al.
NEUROLOGICAL SCIENCES (2021)
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets?
Maria Consiglia Trotta et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy (vol 2016, 7368389, 2016)
S. Rossi et al.
MEDIATORS OF INFLAMMATION (2021)
Targeting Neurovascular Interaction in Retinal Disorders
Zhongjie Fu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR)
Chiara Bianca Maria Platania et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment
Tibor Stark et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors
Francesca Lazzara et al.
FRONTIERS IN PHARMACOLOGY (2020)
OCT Analysis in Patients with Relapsing-Remitting Multiple Sclerosis during Fingolimod Therapy: 2-Year Longitudinal Retrospective Study
Settimio Rossi et al.
APPLIED SCIENCES-BASEL (2020)
TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy
Vincenza Bonfiglio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis
Mario Fruschelli et al.
INTERNATIONAL OPHTHALMOLOGY (2019)
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa
Chiara Bianca Maria Platania et al.
DRUG DELIVERY (2019)
Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis
Riccardo Cheloni et al.
BMJ OPEN (2019)
Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach
Chiara Bianca Maria Platania et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway
Francesca Lazzara et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication
Francesco Merlino et al.
ORGANIC LETTERS (2019)
Sphingosine-1-Phosphate and Macrophage Biology-How the Sphinx Tames the Big Eater
Andreas Weigert et al.
FRONTIERS IN IMMUNOLOGY (2019)
The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome
Maria Consiglia Trotta et al.
PLOS ONE (2019)
Contribution of Angiogenesis to Inflammation and Cancer
Dolores Aguilar-Cazares et al.
FRONTIERS IN ONCOLOGY (2019)
Role of Inflammation in Diabetic Retinopathy
Anne Rubsam et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors
Francesco Merlino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies
Claudio Bucolo et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
Melanocortin receptor agonists MCR1-5 protect photoreceptors from high-glucose damage and restore antioxidant enzymes in primary retinal cell culture
Rosa Maisto et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Association between Aqueous Cytokines and Diabetic Retinopathy Stage
Hailiang Wu et al.
JOURNAL OF OPHTHALMOLOGY (2017)
Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis
Tommaso Bonfiglio et al.
PLOS ONE (2017)
Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy
Joseph D. Boss et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Elia J. Duh et al.
JCI INSIGHT (2017)
A sphingosine-1-phosphate receptor type 1 agonist, ASP4058, suppresses intracranial aneurysm through promoting endothelial integrity and blocking macrophage transmigration
Rie Yamamoto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Local and Systemic Inflammatory Biomarkers of Diabetic Retinopathy: An Integrative Approach
Stela Vujosevic et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
FTY720 Attenuates Retinal Inflammation and Protects Blood-Retinal Barrier in Diabetic Rats
Lingling Fan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor
Alfonso Carotenuto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Altered Expression of NF-κB and SP1 after Exposure to Advanced Glycation End-Products and Effects of Neurotrophic Factors in AGEs Exposed Rat Retinas
Guzel Bikbova et al.
JOURNAL OF DIABETES RESEARCH (2015)
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Simona F. Spampinato et al.
PLOS ONE (2015)
Ocular Anti-VEGF Therapy for Diabetic Retinopathy: Overview of Clinical Efficacy and Evolving Applications
Ning Cheung et al.
DIABETES CARE (2014)
A preliminary evaluation of VEGF-A, VEGFR1 and VEGFR2 in patients with well-controlled type 2 diabetes mellitus
Barbara Ruszkowska-Ciastek et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2014)
Hypothalamic S1P/S1PR1 axis controls energy homeostasis
Vagner R. R. Silva et al.
NATURE COMMUNICATIONS (2014)
Efficacy of Combination Treatment with Fingolimod (FTY720) Plus Pathogenic Autoantigen in a Glucose-6-phosphate Isomerase Peptide (GPI325–339)-Induced Arthritis Mouse Model
Yuya Yoshida et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
Sphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cells
Naveen Sharma et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Fingolimod treatment in multiple sclerosis leads to increased macular volume
Rachel Nolan et al.
NEUROLOGY (2013)
Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
Stuart M. Cahalan et al.
MOLECULAR PHARMACOLOGY (2013)
Homology Modeling of Dopamine D2 and D3 Receptors: Molecular Dynamics Refinement and Docking Evaluation
Chiara Bianca Maria Platania et al.
PLOS ONE (2012)
Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis
M. Mehling et al.
NEUROLOGY (2011)
In Vivo Ocular Efficacy Profile of Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, in Rabbit Models of Ocular Disease
Afshin Shafiee et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Structure and Function of VEGF Receptors
Edward Stuttfeld et al.
IUBMB LIFE (2009)
Blockade of Sphingosine-1-Phosphate Reduces Macrophage Influx and Retinal and Choroigal Neovascularization
Bing Xie et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Modulation of ocular inflammatory responses by EP1 receptors in mice
S. Biswas et al.
EXPERIMENTAL EYE RESEARCH (2007)
Neuroactive steroids protect retinal pigment epithelium against oxidative stress
C Bucolo et al.
NEUROREPORT (2005)
The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors
MH Graler et al.
FASEB JOURNAL (2004)
分享论文
